In this episode of Paul Talks Science, we delve into groundbreaking research led by Dr. Carl Chen, PhD, Medical Scientist and Researcher at the Strengthening Oncology Services Research Unit, Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand.

Dr. Chen and his team recently published a landmark study in Nature Genetics titled “Genomic risk loci for prostate cancer in men of African descent” (DOI: ⁠10.1038/s41588-024-01931-3⁠). This largest genome-wide study of prostate cancer in Africa uncovered unique genetic markers that provide critical insights into why men of African descent face higher prostate cancer risks.

In this conversation, Paul Adepoju, PhD, explores the challenges of studying cancer in Africa, the importance of genetic diversity in research, and how these findings could reshape prostate cancer care globally. Learn about the cutting-edge tools used by the team, the collaborative power of African scientists, and what this research means for healthcare equity and innovation.

🎧 Hit play to uncover the genetic secrets transforming prostate cancer research in Africa.

👉 Subscribe for more conversations at the intersection of science, health, and society.